CORBION NV (CRBN.AS) Stock Fundamental Analysis

Europe • Euronext Amsterdam • AMS:CRBN • NL0010583399

21.08 EUR
+0.06 (+0.29%)
Last: Feb 9, 2026, 07:00 PM
Fundamental Rating

5

CRBN gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 73 industry peers in the Chemicals industry. Both the profitability and the financial health of CRBN get a neutral evaluation. Nothing too spectacular is happening here. CRBN is valued quite cheap, but it does not seem to be growing. This makes CRBN very considerable for value investing!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • CRBN had positive earnings in the past year.
  • CRBN had a positive operating cash flow in the past year.
  • CRBN had positive earnings in each of the past 5 years.
  • CRBN had a positive operating cash flow in each of the past 5 years.
CRBN.AS Yearly Net Income VS EBIT VS OCF VS FCFCRBN.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 4.57%, CRBN is in the better half of the industry, outperforming 67.12% of the companies in the same industry.
  • CRBN's Return On Equity of 9.14% is fine compared to the rest of the industry. CRBN outperforms 63.01% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 9.22%, CRBN is in the better half of the industry, outperforming 73.97% of the companies in the same industry.
  • CRBN had an Average Return On Invested Capital over the past 3 years of 6.62%. This is in line with the industry average of 7.31%.
  • The last Return On Invested Capital (9.22%) for CRBN is above the 3 year average (6.62%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 4.57%
ROE 9.14%
ROIC 9.22%
ROA(3y)7.34%
ROA(5y)6.93%
ROE(3y)16.91%
ROE(5y)15.8%
ROIC(3y)6.62%
ROIC(5y)7.13%
CRBN.AS Yearly ROA, ROE, ROICCRBN.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

  • With a Profit Margin value of 5.12%, CRBN perfoms like the industry average, outperforming 58.90% of the companies in the same industry.
  • In the last couple of years the Profit Margin of CRBN has grown nicely.
  • CRBN has a Operating Margin (8.70%) which is in line with its industry peers.
  • In the last couple of years the Operating Margin of CRBN has declined.
  • CRBN has a worse Gross Margin (26.10%) than 61.64% of its industry peers.
  • CRBN's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 8.7%
PM (TTM) 5.12%
GM 26.1%
OM growth 3Y1.69%
OM growth 5Y-4.15%
PM growth 3Y26.84%
PM growth 5Y41.37%
GM growth 3Y-0.41%
GM growth 5Y-2.31%
CRBN.AS Yearly Profit, Operating, Gross MarginsCRBN.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

5

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CRBN is creating some value.
  • The number of shares outstanding for CRBN has been reduced compared to 1 year ago.
  • CRBN has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for CRBN has been reduced compared to a year ago.
CRBN.AS Yearly Shares OutstandingCRBN.AS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
CRBN.AS Yearly Total Debt VS Total AssetsCRBN.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

  • An Altman-Z score of 2.87 indicates that CRBN is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 2.87, CRBN is in the better half of the industry, outperforming 64.38% of the companies in the same industry.
  • CRBN has a debt to FCF ratio of 4.92. This is a neutral value as CRBN would need 4.92 years to pay back of all of its debts.
  • CRBN has a better Debt to FCF ratio (4.92) than 71.23% of its industry peers.
  • CRBN has a Debt/Equity ratio of 0.39. This is a healthy value indicating a solid balance between debt and equity.
  • CRBN has a Debt to Equity ratio of 0.39. This is comparable to the rest of the industry: CRBN outperforms 54.79% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF 4.92
Altman-Z 2.87
ROIC/WACC1.4
WACC6.6%
CRBN.AS Yearly LT Debt VS Equity VS FCFCRBN.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

  • A Current Ratio of 1.21 indicates that CRBN should not have too much problems paying its short term obligations.
  • CRBN has a worse Current ratio (1.21) than 78.08% of its industry peers.
  • CRBN has a Quick Ratio of 1.21. This is a bad value and indicates that CRBN is not financially healthy enough and could expect problems in meeting its short term obligations.
  • CRBN has a worse Quick ratio (0.60) than 84.93% of its industry peers.
Industry RankSector Rank
Current Ratio 1.21
Quick Ratio 0.6
CRBN.AS Yearly Current Assets VS Current LiabilitesCRBN.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

3

3. Growth

3.1 Past

  • The earnings per share for CRBN have decreased strongly by -68.92% in the last year.
  • CRBN shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 49.47% yearly.
  • Looking at the last year, CRBN shows a small growth in Revenue. The Revenue has grown by 2.95% in the last year.
  • CRBN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.70% yearly.
EPS 1Y (TTM)-68.92%
EPS 3Y34.95%
EPS 5Y49.47%
EPS Q2Q%-74.51%
Revenue 1Y (TTM)2.95%
Revenue growth 3Y6.35%
Revenue growth 5Y5.7%
Sales Q2Q%1.33%

3.2 Future

  • CRBN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.24% yearly.
  • CRBN is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -1.71% yearly.
EPS Next Y36.96%
EPS Next 2Y22.71%
EPS Next 3Y19.54%
EPS Next 5Y15.24%
Revenue Next Year-2.4%
Revenue Next 2Y-0.19%
Revenue Next 3Y1.19%
Revenue Next 5Y-1.71%

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CRBN.AS Yearly Revenue VS EstimatesCRBN.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B
CRBN.AS Yearly EPS VS EstimatesCRBN.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5

7

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 18.82, which indicates a rather expensive current valuation of CRBN.
  • Based on the Price/Earnings ratio, CRBN is valued a bit cheaper than 64.38% of the companies in the same industry.
  • CRBN is valuated rather cheaply when we compare the Price/Earnings ratio to 28.06, which is the current average of the S&P500 Index.
  • The Price/Forward Earnings ratio is 13.91, which indicates a correct valuation of CRBN.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of CRBN indicates a somewhat cheap valuation: CRBN is cheaper than 78.08% of the companies listed in the same industry.
  • CRBN is valuated cheaply when we compare the Price/Forward Earnings ratio to 27.86, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 18.82
Fwd PE 13.91
CRBN.AS Price Earnings VS Forward Price EarningsCRBN.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, CRBN is valued a bit cheaper than the industry average as 64.38% of the companies are valued more expensively.
  • CRBN's Price/Free Cash Flow ratio is rather cheap when compared to the industry. CRBN is cheaper than 93.15% of the companies in the same industry.
Industry RankSector Rank
P/FCF 12.23
EV/EBITDA 8.51
CRBN.AS Per share dataCRBN.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • CRBN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • CRBN has a very decent profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as CRBN's earnings are expected to grow with 19.54% in the coming years.
PEG (NY)0.51
PEG (5Y)0.38
EPS Next 2Y22.71%
EPS Next 3Y19.54%

6

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 3.09%, CRBN has a reasonable but not impressive dividend return.
  • CRBN's Dividend Yield is a higher than the industry average which is at 2.26.
  • Compared to an average S&P500 Dividend Yield of 1.80, CRBN pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.09%

5.2 History

  • The dividend of CRBN has a limited annual growth rate of 5.02%.
Dividend Growth(5Y)5.02%
Div Incr Years1
Div Non Decr Years5
CRBN.AS Yearly Dividends per shareCRBN.AS Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

  • CRBN pays out 56.02% of its income as dividend. This is a bit on the high side, but may be sustainable.
  • CRBN's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP56.02%
EPS Next 2Y22.71%
EPS Next 3Y19.54%
CRBN.AS Yearly Income VS Free CF VS DividendCRBN.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M
CRBN.AS Dividend Payout.CRBN.AS Dividend Payout, showing the Payout Ratio.CRBN.AS Dividend Payout.PayoutRetained Earnings

CORBION NV

AMS:CRBN (2/9/2026, 7:00:00 PM)

21.08

+0.06 (+0.29%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)N/A
Earnings (Next)02-26
Inst Owners92.92%
Inst Owner ChangeN/A
Ins Owners0.22%
Ins Owner ChangeN/A
Market Cap1.23B
Revenue(TTM)1.30B
Net Income(TTM)66.40M
Analysts78.57
Price Target24.12 (14.42%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.09%
Yearly Dividend0.71
Dividend Growth(5Y)5.02%
DP56.02%
Div Incr Years1
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.85%
PT rev (3m)5.85%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.26%
EPS NY rev (3m)0.26%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.61%
Valuation
Industry RankSector Rank
PE 18.82
Fwd PE 13.91
P/S 0.95
P/FCF 12.23
P/OCF 7.28
P/B 1.69
P/tB 1.94
EV/EBITDA 8.51
EPS(TTM)1.12
EY5.31%
EPS(NY)1.52
Fwd EY7.19%
FCF(TTM)1.72
FCFY8.18%
OCF(TTM)2.9
OCFY13.74%
SpS22.26
BVpS12.47
TBVpS10.88
PEG (NY)0.51
PEG (5Y)0.38
Graham Number17.72
Profitability
Industry RankSector Rank
ROA 4.57%
ROE 9.14%
ROCE 10.95%
ROIC 9.22%
ROICexc 9.59%
ROICexgc 10.58%
OM 8.7%
PM (TTM) 5.12%
GM 26.1%
FCFM 7.74%
ROA(3y)7.34%
ROA(5y)6.93%
ROE(3y)16.91%
ROE(5y)15.8%
ROIC(3y)6.62%
ROIC(5y)7.13%
ROICexc(3y)7.16%
ROICexc(5y)7.83%
ROICexgc(3y)8.31%
ROICexgc(5y)9.44%
ROCE(3y)7.87%
ROCE(5y)8.47%
ROICexgc growth 3Y0.82%
ROICexgc growth 5Y-11.84%
ROICexc growth 3Y3.78%
ROICexc growth 5Y-8.06%
OM growth 3Y1.69%
OM growth 5Y-4.15%
PM growth 3Y26.84%
PM growth 5Y41.37%
GM growth 3Y-0.41%
GM growth 5Y-2.31%
F-Score6
Asset Turnover0.89
Health
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF 4.92
Debt/EBITDA 1.43
Cap/Depr 80.83%
Cap/Sales 5.27%
Interest Coverage 7.23
Cash Conversion 85.5%
Profit Quality 151.21%
Current Ratio 1.21
Quick Ratio 0.6
Altman-Z 2.87
F-Score6
WACC6.6%
ROIC/WACC1.4
Cap/Depr(3y)194.04%
Cap/Depr(5y)192.31%
Cap/Sales(3y)11.51%
Cap/Sales(5y)11.48%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-68.92%
EPS 3Y34.95%
EPS 5Y49.47%
EPS Q2Q%-74.51%
EPS Next Y36.96%
EPS Next 2Y22.71%
EPS Next 3Y19.54%
EPS Next 5Y15.24%
Revenue 1Y (TTM)2.95%
Revenue growth 3Y6.35%
Revenue growth 5Y5.7%
Sales Q2Q%1.33%
Revenue Next Year-2.4%
Revenue Next 2Y-0.19%
Revenue Next 3Y1.19%
Revenue Next 5Y-1.71%
EBIT growth 1Y54.95%
EBIT growth 3Y8.15%
EBIT growth 5Y1.31%
EBIT Next Year128.83%
EBIT Next 3Y37.35%
EBIT Next 5Y26.73%
FCF growth 1Y172.18%
FCF growth 3YN/A
FCF growth 5Y21.2%
OCF growth 1Y119.09%
OCF growth 3Y101.81%
OCF growth 5Y9.98%

CORBION NV / CRBN.AS FAQ

What is the fundamental rating for CRBN stock?

ChartMill assigns a fundamental rating of 5 / 10 to CRBN.AS.


What is the valuation status of CORBION NV (CRBN.AS) stock?

ChartMill assigns a valuation rating of 6 / 10 to CORBION NV (CRBN.AS). This can be considered as Fairly Valued.


What is the profitability of CRBN stock?

CORBION NV (CRBN.AS) has a profitability rating of 6 / 10.


What is the earnings growth outlook for CORBION NV?

The Earnings per Share (EPS) of CORBION NV (CRBN.AS) is expected to grow by 36.96% in the next year.


How sustainable is the dividend of CORBION NV (CRBN.AS) stock?

The dividend rating of CORBION NV (CRBN.AS) is 6 / 10 and the dividend payout ratio is 56.02%.